Yangzhou Liberty Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding US DMF Number 13174.
Remarkably, this DMF maintains an Active status since its submission on September 10, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 14, 2014, and payment made on December 31, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II